InvestorsHub Logo
Followers 6
Posts 2155
Boards Moderated 0
Alias Born 11/26/2014

Re: Tekterra post# 26377

Tuesday, 04/25/2017 11:09:28 AM

Tuesday, April 25, 2017 11:09:28 AM

Post# of 38634
Tek- The bad news that could happen would be no Seroquel final approval. I personally think this approval will go through and products will begin shipping. If this approval is going to happen, it will definitely not happen this week and will likely happen next week. Small chance it happens the second week in May but if nothing by then, there is likely a problem. Like I said, I think we hear next week.

Other income generation that would really help is approval of Pristiq and Lamictal. There is a strong possibility that one or both of these gets approved in 2017.

I personally believe Gluco will be partnered. As has been pointed out, the cost per pill is very low, so that means means margins are low. I do not think Gluco is a good fit for IPCI to manufacture. I could be wrong but it seems you would need a very efficient operation to manufacture this product and make money. That limits the scope of potential partners. Like I said, I think they will partner but I am guessing the revenue generated by this product will be low.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y